Suppr超能文献

肥胖起病青年型糖尿病突变患者与 2 型糖尿病患者的胰岛β细胞功能和胰岛素敏感性: TODAY 的纵向观察和血糖失败。

Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.

机构信息

UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.

George Washington University Biostatistics Center, Rockville, Maryland.

出版信息

Pediatr Diabetes. 2020 Jun;21(4):575-585. doi: 10.1111/pedi.12998. Epub 2020 Mar 3.

Abstract

OBJECTIVE

In treatment options for type 2 diabetes in adolescents and youth (TODAY), 4.5% of obese youth clinically diagnosed with type 2 diabetes (T2D) had genetic variants consistent with maturity onset diabetes of youth (MODY) diagnosis. The course of IS and β-cell function in obese youth with MODY remains unknown. In this secondary analysis, we examined IS and β-cell function in MODY vs. non-MODY obese youth at randomization and over time.

METHODS

Genetic data in TODAY included 426 non-MODY (T2D) and 22 MODY youth (7 glucokinase MODY mutation positive [GCK-MODY], 12 hepatocyte nuclear factor MODY mutation positive [HNF-MODY], 2 Insulin gene mutation [insulin (INS)-MODY], and 1 Kruppel-like factor 11 [KLF11-MODY]). Oral glucose tolerance test (OGTT)-derived IS, C-peptide index, and β-cell function relative to IS oral disposition index (oDI) was measured at randomization, and over 24 months in addition to total and high-molecular-weight adiponectin (HMWA).

RESULTS

At randomization, IS, total adiponectin, and HMWA were significantly higher in the two MODY groups than in non-MODY. β-cell function measured by C-peptide oDI was 3-fold higher in GCK-MODY than in HNF-MODY and 1.5-fold higher than non-MODY (P for both <.05). Glycemic failure rate was 75.0% in HNF-MODY, 46.9% in non-MODY, and zero in GCK-MODY youth. While the changes in IS and oDI were not different among the three groups in the first 6 months, IS improved from 6 to 24 months in HNF-MODY vs GCK-MODY youth.

CONCLUSIONS

In TODAY, β-cell function at randomization was worse in obese HNF-MODY youth compared with GCK-MODY youth, while insulin sensitivity was worse in non-MODY compared with the other two MODY groups. Over time, IS showed the greatest improvement in HNF-MODY youth. This raises the possibility that TODAY therapeutic modalities of insulin sensitization in these obese HNF-MODY youth may have played a beneficial role.

摘要

目的

在治疗青少年和儿童 2 型糖尿病的 TODAY 研究中,4.5%的肥胖青少年临床诊断为 2 型糖尿病(T2D),存在与青少年起病的成年型糖尿病(MODY)一致的基因突变。MODY 肥胖青少年的胰岛素分泌(IS)和 β 细胞功能的病程尚不清楚。在本次二次分析中,我们在随机分组时和随访期间,检测了 MODY 与非 MODY 肥胖青少年的 IS 和 β 细胞功能。

方法

TODAY 中的遗传数据包括 426 名非 MODY(T2D)和 22 名 MODY 青少年(7 名葡萄糖激酶 MODY 突变阳性[GCK-MODY]、12 名肝细胞核因子 MODY 突变阳性[HNF-MODY]、2 名胰岛素基因突变[胰岛素(INS)-MODY]和 1 名 Kruppel 样因子 11[KLF11-MODY])。在随机分组时,以及随访 24 个月时,我们进行了口服葡萄糖耐量试验(OGTT)衍生的 IS、C 肽指数和 IS 口服处置指数(oDI)相对于 β 细胞功能的测定,此外还测定了总和高分子量脂联素(HMWA)。

结果

在随机分组时,与非 MODY 相比,GCK-MODY 和 HNF-MODY 两组的 IS、总脂联素和 HMWA 均显著升高。GCK-MODY 的 C 肽 oDI 测定的 β 细胞功能是 HNF-MODY 的 3 倍,是非 MODY 的 1.5 倍(均 P<0.05)。HNF-MODY 青少年的血糖控制失败率为 75.0%,非 MODY 为 46.9%,GCK-MODY 为 0%。在前 6 个月内,三组之间的 IS 和 oDI 变化无差异,但 HNF-MODY 青少年的 IS 从 6 个月改善至 24 个月。

结论

在 TODAY 研究中,与 GCK-MODY 青少年相比,肥胖的 HNF-MODY 青少年在随机分组时的 β 细胞功能更差,而与其他两个 MODY 组相比,非 MODY 青少年的胰岛素敏感性更差。随着时间的推移,HNF-MODY 青少年的 IS 改善最为明显。这提示,在这些肥胖的 HNF-MODY 青少年中,TODAY 的胰岛素增敏治疗方法可能发挥了有益作用。

相似文献

10

本文引用的文献

5
HNF1α defect influences post-prandial lipid regulation.肝细胞核因子1α缺陷影响餐后脂质调节。
PLoS One. 2017 May 11;12(5):e0177110. doi: 10.1371/journal.pone.0177110. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验